|
 |
|
Innovative Pap Smear/HPV Testing Technologies
And Emerging Markets
This report contains 243 pages, 7 tables and presents a detailed analysis of the Pap Smear/HPV testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5- and 10-year test volume and sales forecasts by country and market segment.
|
 |
|
$3850.00 |
| |
|
|
|
Innovative PSA Testing Technologies and Emerging Markets
This report contains 249 pages, 15 tables and presents a detailed analysis of the PSA testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5- and 10-year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers.
|
|
|
$3850.00 |
| |
|
|
|
US Cancer Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers
This report presents a comprehensive analysis of the US cancer diagnostics market, including:�- Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Mortality statistics and scientific views on the etiology of major types of cancer, e....
|
|
|
$3850.00 |
| |
|
|
|
Tumor Marker Diagnostic Analyzers and Strategic Profiles of Leading Suppliers
This 119-page report reviews current instrumentation technologies, and compares features of major automated and semiautomated analyzers used for cancer diagnostic testing.
|
|
|
$3850.00 |
| |
|
|
|
Analysis of the World Cancer Diagnostics Market:
Sales Forecasts by Country and Strategic Profiles of Leading Suppliers
This report provides estimates of the number of laboratories performing cancer tests, as well as test volume and sales forecasts by country.
|
|
|
$3500.00 |
| |
|
|
|
Analysis of Cancer Diagnostic Testing Instrumentation
And Strategic Profiles of Leading Suppliers
This 119-page report reviews current instrumentation technologies, and compares features of major automated and semiautomated analyzers used for cancer diagnostic testing.
|
|
|
$3500.00 |
| |
|
|
|
Analysis of Cancer Diagnostic Technologies
And Strategic Profiles of Leading Suppliers
This 185-page report provides detailed assessments of such technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for cancer diagnostic testing. Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics spectroscopy.
|
|
|
$3500.00 |
| |
|
|
|
French Cancer Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers
This report presents a comprehensive analysis of the French cancer diagnostics market, including:- Major issues pertaining to the French laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Mortality statistics and scientific views on the etiology of major types of cancer, e....
|
|
|
$3500.00 |
| |
|
|
|
German Cancer Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers
This report presents a comprehensive analysis of the German cancer diagnostics market, including:- Major issues pertaining to the German laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Mortality statistics and scientific views on the etiology of major types of cancer, e....
|
|
|
$3500.00 |
| |
|
|
|
Italian Cancer Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers
This report presents a comprehensive analysis of the Italian cancer diagnostics market, including:- Major issues pertaining to the Italian laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Mortality statistics and scientific views on the etiology of major types of cancer, e....
|
|
|
$3500.00 |
| |
|
|
|
Japanese Cancer Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers
This report presents a comprehensive analysis of the Japanese cancer diagnostics market, including:- Major issues pertaining to the Japanese laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Mortality statistics and scientific views on the etiology of major types of cancer, e....
|
|
|
$3500.00 |
| |
|
|
|
Spanish Cancer Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers
This report presents a comprehensive analysis of the Spanish cancer diagnostics market, including:- Major issues pertaining to the Spanish laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Mortality statistics and scientific views on the etiology of major types of cancer, e....
|
|
|
$3500.00 |
| |
|
|
|
UK Cancer Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers
This report presents a comprehensive analysis of the UK cancer diagnostics market, including:- Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Mortality statistics and scientific views on the etiology of major types of cancer, e....
|
|
|
$3500.00 |
| |
|
|
|
France Sales and Market Shares of Major Cancer Diagnostic Testing Product Suppliers by Assay and Country
This unique report from Venture Planning Group provides France sales and market share estimates for major suppliers of cancer diagnostic testing products by assay and country.The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
|
|
|
$3200.00 |
| |
|
|
|
Japan Sales and Market Shares of Major Cancer Diagnostic Testing Product Suppliers by Assay and Country
This unique report from Venture Planning Group provides Japan sales and market share estimates for major suppliers of cancer diagnostic testing products by assay and country.The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
|
|
|
$3000.00 |
| |
|
|
|
Germany Sales and Market Shares of Major Cancer Diagnostic Testing Product Suppliers by Assay and Country
This unique report from Venture Planning Group provides Germany sales and market share estimates for major suppliers of cancer diagnostic testing products by assay and country.The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
|
|
|
$2950.00 |
| |
|
|
|
Spain Sales and Market Shares of Major Cancer Diagnostic Testing Product Suppliers by Assay and Country
This unique report from Venture Planning Group provides Spain sales and market share estimates for major suppliers of cancer diagnostic testing products by assay and country.The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
|
|
|
$2950.00 |
| |
|
|
|
World Cell Surface Markers Testing Market: Emerging Opportunities, Country Forecasts, Innovative Technologies, Competitive Landscape--US, Europe (France, Germany, Italy, Spain, UK), Japan
The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination of the hybridoma technology with flow cytometry is further expanding the applications of both technologies....
|
|
|
$2900.00 |
| |
|
|
|
|